ketoconazole has been researched along with Diabetes Mellitus, Type 1 in 10 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a patient with type I diabetes mellitus and hypothyroidism who developed frank adrenocortical insufficiency while receiving a high-dose ketoconazole therapy for keratitis caused by Acanthamoeba species." | 3.67 | Adrenal crisis in the setting of high-dose ketoconazole therapy. ( Demerjian, Z; Godine, JE; Khosla, S; Wolfson, JS, 1989) |
| "Mucormycosis is an uncommon condition caused by opportunistic infection in immunodepressed subjects." | 2.40 | [Paranasal mucormycosis with involvement of the sphenoid sinus]. ( Dumollard, JM; Lefort, T; Seguin, P; Sokolo, R; Soulhiard, F, 1998) |
| "Onychomycosis is an infection of the nail unit by a fungus." | 1.43 | Onychomycosis in diabetic patients in Fako Division of Cameroon: prevalence, causative agents, associated factors and antifungal sensitivity patterns. ( Atashili, J; Eba, M; Fuh, AN; Kwenti, ET; Mouliom, RN; Nchanji, GT; Njunda, AL, 2016) |
| "isolates for ketoconazole from type 1 diabetes patients was significantly higher than that of its matched control." | 1.37 | Prevalence and antifungal resistance profile of Candida spp. oral isolates from patients with type 1 and 2 diabetes mellitus. ( Back-Brito, GN; Balducci, I; Bremenkamp, RM; Brighenti, FL; Caris, AR; Jorge, AO; Koga-Ito, CY; Mota, AJ, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (30.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eba, M | 1 |
| Njunda, AL | 1 |
| Mouliom, RN | 1 |
| Kwenti, ET | 1 |
| Fuh, AN | 1 |
| Nchanji, GT | 1 |
| Atashili, J | 1 |
| Bremenkamp, RM | 1 |
| Caris, AR | 1 |
| Jorge, AO | 1 |
| Back-Brito, GN | 1 |
| Mota, AJ | 1 |
| Balducci, I | 1 |
| Brighenti, FL | 1 |
| Koga-Ito, CY | 1 |
| Kendirci, M | 1 |
| Koç, AN | 1 |
| Kurtoglu, S | 1 |
| Keskin, M | 1 |
| Kuyucu, T | 1 |
| Eschard, JP | 1 |
| Poynard, JP | 1 |
| Janody, D | 1 |
| Ricard, Y | 1 |
| Diebold, MD | 1 |
| Gari, M | 1 |
| Leutenegger, M | 1 |
| Stratta, RJ | 1 |
| Taylor, RJ | 1 |
| Weide, LG | 1 |
| Sindhi, R | 1 |
| Sudan, D | 1 |
| Castaldo, P | 1 |
| Cushing, KA | 1 |
| Frisbie, K | 1 |
| Radio, SJ | 1 |
| Sokolo, R | 1 |
| Lefort, T | 1 |
| Soulhiard, F | 1 |
| Dumollard, JM | 1 |
| Seguin, P | 1 |
| Bech, P | 1 |
| Raabaek Olsen, L | 1 |
| Jarløv, N | 1 |
| Hammer, M | 1 |
| Schütze, T | 1 |
| Breum, L | 1 |
| Nichols, R | 1 |
| Khosla, S | 1 |
| Wolfson, JS | 1 |
| Demerjian, Z | 1 |
| Godine, JE | 1 |
| Cohen, PS | 1 |
| Scheer, RL | 1 |
| Bloom, MJ | 1 |
| Kolanchik, GJ | 1 |
| Tucker, JB | 1 |
2 reviews available for ketoconazole and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
[Paranasal mucormycosis with involvement of the sphenoid sinus].
Topics: Aged; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Diabetes Mellitus, Type 1; Femal | 1998 |
Problems associated with medical therapy of canine hyperadrenocorticism.
Topics: Adrenal Cortex Neoplasms; Adrenocortical Hyperfunction; Animals; Cushing Syndrome; Diabetes Mellitus | 1990 |
2 trials available for ketoconazole and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Vulvovaginal candidiasis in children and adolescents with type 1 diabetes mellitus.
Topics: Adolescent; Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Child; Child, Preschool; D | 2004 |
A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients.
Topics: Adult; Antilymphocyte Serum; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Female; Follow-Up St | 1996 |
6 other studies available for ketoconazole and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Onychomycosis in diabetic patients in Fako Division of Cameroon: prevalence, causative agents, associated factors and antifungal sensitivity patterns.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cameroon; Cross-Sectional Studies | 2016 |
Prevalence and antifungal resistance profile of Candida spp. oral isolates from patients with type 1 and 2 diabetes mellitus.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis, Oral; Case-Control Studies; Child; | 2011 |
[Cutaneous mucormycosis in a diabetic woman. Diagnostic and therapeutic problems].
Topics: Amphotericin B; Bandages; Casts, Surgical; Dermatomycoses; Diabetes Mellitus, Type 1; Female; Humans | 1984 |
A case of sequential anti-stress medication in a patient with major depression resistant to amine-reuptake inhibitors.
Topics: Amines; Antidepressive Agents; Anxiety Disorders; Dehydroepiandrosterone; Depressive Disorder, Major | 1999 |
Adrenal crisis in the setting of high-dose ketoconazole therapy.
Topics: Acanthamoeba; Acute Disease; Adrenal Cortex Diseases; Amebiasis; Animals; Diabetes Mellitus, Type 1; | 1989 |
Candida tropicalis papillary necrosis treated with ketoconazole.
Topics: Adult; Candidiasis; Diabetes Mellitus, Type 1; Humans; Ketoconazole; Kidney Papillary Necrosis; Male | 1985 |